前列腺素E2/EP2受体信号通路促进糖尿病大鼠视网膜病变
该研究在链脲佐菌素诱导的糖尿病大鼠模型中,通过玻璃体腔注射前列腺素E2、EP2受体激动剂布他前列素或拮抗剂AH6809,评估视网膜血管渗漏、白细胞停滞和内皮细胞凋亡。结果显示PGE2/EP2R信号通路参与糖尿病视网膜病变,拮抗该通路可减轻上述病理改变。
要点
- 玻璃体腔注射PGE2或布他前列素加速糖尿病大鼠视网膜血管渗漏、白细胞停滞和内皮细胞凋亡。
- AH6809预处理可减轻上述视网膜病变表现。
- PGE2/EP2R信号通路可能成为糖尿病视网膜病变防治的潜在靶点。
核心结论
- PGE2/EP2R信号通路参与链脲佐菌素诱导的糖尿病视网膜病变,可作为防治的潜在靶点。
研究设计与样本
- 在链脲佐菌素诱导的糖尿病大鼠模型中,玻璃体腔注射PGE2、布他前列素(PGE2/EP2R激动剂)或AH6809(EP2R拮抗剂),评估视网膜组织学、光学相干断层扫描、视网膜血管超微结构和生化标志物。
- 体外使用人视网膜微血管内皮细胞,以AH6809预处理后观察PGE2和布他前列素诱导的caspase 1活化、NLRP3-ASC复合物活化及EP2R偶联的cAMP/PKA/CREB信号通路活化。
主要发现
- 玻璃体腔注射PGE2和布他前列素显著加速链脲佐菌素诱导的糖尿病大鼠视网膜血管渗漏、白细胞停滞和内皮细胞凋亡。
- AH6809预处理的糖尿病大鼠上述反应减轻。
- AH6809预处理的人视网膜微血管内皮细胞中,PGE2和布他前列素诱导的caspase 1活化、NLRP3-ASC复合物活化及EP2R偶联的cAMP/PKA/CREB信号通路活化均减弱。
临床怎么用
- 该研究提示拮抗EP2R可能减轻糖尿病视网膜病变中的炎症和微血管功能障碍,但尚需临床研究验证。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Diabetic retinopathy is a common microvascular complication of diabetes mellitus and is initiated by inflammation and apoptosis-associated retinal endothelial cell damage. Prostaglandin E2 (PGE2) has emerged as a critical regulator of these biological processes. We hypothesised that modulating PGE2 and its E-prostanoid receptor (EP2R) would prevent diabetes mellitus-induced inflammation and microvascular dysfunction. METHODS: In a streptozotocin (STZ)-induced rat model of diabetes, rats received intravitreal injection of PGE2, butaprost (a PGE2/EP2R agonist) or AH6809 (an EP2R antagonist). Retinal histology, optical coherence tomography, ultrastructure of the retinal vascular and biochemical markers were assessed. RESULTS: Intravitreal injection of PGE2 and butaprost significantly accelerated retinal vascular leakage, leucostasis and endothelial cell apoptosis in STZ-induced diabetic rats. This response was ameliorated in diabetic rats pre-treated with AH6809. In addition, pre-treatment of human retinal microvascular endothelial cells with AH6809 attenuated PGE2- and butaprost-induced activation of caspase 1, activation of the complex containing nucleotide-binding domain and leucine rich repeat containing family, pyrin domain containing 3 (NLRP3) and apoptosis-associated speck-like protein containing a C-terminal caspase-activation and recruitment domain (ASC), and activation of the EP2R-coupled cAMP/protein kinase A/cAMP response element-binding protein signalling pathway. CONCLUSIONS/INTERPRETATION: The PGE2/EP2R signalling pathway is involved in STZ-induced diabetic retinopathy and could be considered as a potential target for diabetic retinopathy prevention and treatment.
引用
- Wang M, Wang Y, Xie T, et al. Prostaglandin E2/EP2 receptor signalling pathway promotes diabetic retinopathy in a rat model of diabetes. Diabetologia. 2018. PMID: 30411254. doi:10.1007/s00125-018-4755-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。